Cancer is a large group of diseases that can start in almost any organ or tissue of the body when abnormal cells grow uncontrollably, go beyond their usual boundaries to invade adjoining parts of the body, and/or spread to other organs. The latter process is called metastasizing and is a major cause of death from cancer. A neoplasm and malignant tumor are other common names for cancer. Tumor biomarkers test used in the diagnosis of cancer include, prostate-specific antigen (PSA), circulating tumor cells (CTC), Alfa-fetoprotein test (AFP), CA-19 test for pancreatic cancer, HER-2 test, BRCA test, ALK test for lung cancer, carcinoembryonic test (CEA), EGFR mutation test, and RAS mutation test.
Market Dynamics
The key market players are focusing on the adoption of growth organic strategies such as launching new cancer diagnostics, which is attributed to the growth of the global cancer diagnostics market. For instance, in March 2020, BD (Becton, Dickinson and Company) a medical technology company, and BioMedomics, a privately held, U.S.-based clinical diagnostics company, announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to PARP biomarker test in as little as 15 minutes. Furthermore, the development of new technologically advanced products for cancer diagnosis is expected to support market growth. In November 2021, Siemens Healthineers launched Naeotom Alpha, the globe's first photon-counting CT Scannerwith improved resolution as well as a reduction in radiation dose by up to 45% for ultra-high resolution scans. Thus, the segment is expected to show growth in the near future due to the above-mentioned factors.
Furthermore, governments and other healthcare organizations are taking initiatives to provide women between 50 to 75 years access to mammography screening. In June 2020, Fujifilm Medical Systems is Medical equipment manufacturer in the U.S.A. announced a new breast cancer screening awareness campaign focused on early detection of the disease in the United States. The ‘Aspire to Be Fearless’ campaign involves a mobile mammography vehicle traveling throughout the United States to spread Fujifilm’s message. The vehicle includes a waiting room, dressing room, and the latest breast imaging solutions from Fujifilm.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook